What Are Traders Saying as Solana Reclaims Spotlight? ETH, DOGE, ADA See Profit-Taking
The move continues a trend that has defined July trading, with slow, steady gains for BTC alongside large breakouts across Layer 1s and decentralized finance (DeFi) tokens.
Bitcoin held firm above $117,400, gaining a little over 1% in the past 24 hours. XRP (XRP), BNB (BNB), dogecoin (DOGE) and Cardano's ADA (ADA) showed mixed movements as traders took profits, while Solana's SOL (SOL) surged 8% to $203, its highest price level since late February.
The strength in SOL came as ecosystem player Jito introduced the Block Assembly Marketplace (BAM) in a move that some observers said boosted investor interest in SOL, as CoinDesk reported.
DeFi bluechips like Uniswap and Aave have posted 20%–30% jumps in the past week. Jeff Mei, COO at BTSE, attributed this to a mix of strong ETF inflows and optimism over the GENIUS Act, a legislative proposal expected to clarify the regulatory path for DeFi platforms.
'Investors are rotating into Ethereum en masse, which explains its sustained rally over the weekend. Bitcoin still remains strong at $117,000, but it's clear that momentum has shifted towards Ethereum - the Ethereum ETFs are seeing record inflows,' Mei said in a note to CoinDesk.
'This makes sense as Ethereum is still trading well below its all-time highs and traders believe it will close the gap in the coming months,' Mei added. At current prices, ETH is still nearly 25% below its record high from 2021, providing swing traders with a defined target to aim for.
As bitcoin cools near its recent highs, some fund managers are already rotating capital into ether, betting that it's next in line for a breakout. Part of that optimism stems from the growing role of ETH in institutional portfolios, especially as U.S. spot ETFs see accelerating inflows.
'We expect that Ethereum will climb back higher against BTC due to institutional support of new reserve strategies while investors fear missing out on an ETH surge similar to Bitcoin's rush to $120,000 this year,' said Nassar Al Achkar, chief strategy officer at CoinW, in a Tuesday note.
Meanwhile, some say that global markets are flashing early signs of a renewed inflationary cycle. Long-dated yields are holding firm at elevated levels across major economies, while inflation breakevens — a key measure of future price pressures — have quietly climbed back to multi-year highs.
'Inflation expectations have creeped back in with long-dated yields staying elevated globally, while inflation breakevens have climbed back to the highest level in years as financial conditions stay loose,' Augustine Fan, head of insights at SignalPlus, said in a Telegram message.
'Crypto has certainly not shied away from our own FOMO moment. It certainly feels like that the good days are back until further notice,' Fan ended.Sign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?
